Transaction DateRecipientSharesTypePriceValue
7th January 2021Brian Lee Baker5,200Open or private sale$121.57$632,164.00
7th January 2021Brian Lee Baker4,545Exercise of derivative$5.12$23,270.40
7th January 2021Brian Lee Baker513Open or private sale$123.02$63,109.26
7th January 2021Brian Lee Baker900Open or private sale$120.16$108,144.00
7th January 2021Brian Lee Baker10,689Exercise of derivative$7.43$79,419.27
7th January 2021Brian Lee Baker1,299Exercise of derivative$3.20$4,156.80
7th January 2021Advisors Llc Orbimed2,000,000Open or private sale$3.50$7,000,000.00
7th January 2021Brian Lee Baker11,905Exercise of derivative$2.19$26,071.95
7th January 2021Brian Lee Baker2,800Open or private sale$122.65$343,420.00
7th January 2021Brian Lee Baker21,825Open or private sale$122.44$2,672,253.00
Turning Point Therapeutics
Turning Point Therapeutics logo

Turning Point Therapeutics, Inc. engages in the discovery and development of precision medicines for cancer and other diseases. The company was founded by J. Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA.


Ticker: TPTX
Sector: Health Technology
Industry: Pharmaceuticals: Major
SEC Central Index Key (CIK): 1595893
Employees: 95
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals